semaglutide news october 2025 🚨 BIG for obesity care!!, The FDA approved an oral Wegovy pill with the active ingredient, semaglutide. This now offers a non-injectable GLP-1 option for patients who won’t do shots. * This video FDA Decisions Expected: October 2025
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



























